Print Page     Close Window     

SEC Filings

S-3
SERES THERAPEUTICS, INC. filed this Form S-3 on 03/16/2017
Entire Document
 
EX-25.1

Exhibit 25.1

File No.             

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM T-1

 

 

STATEMENT OF ELIGIBILITY

UNDER THE TRUST INDENTURE ACT OF 1939

OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE

 

CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2)

 

 

WILMINGTON TRUST, NATIONAL ASSOCIATION

(Exact name of trustee as specified in its charter)

 

 

16-1486454

(I.R.S. employer identification no.)

1100 North Market Street

Wilmington, DE 19890

(Address of principal executive offices)

Tara Aiken

Banking Officer

1100 North Market Street

Wilmington, Delaware 19890

(302) 651-1592

(Name, address and telephone number of agent for service)

 

 

Seres Therapeutics, Inc.

(Exact name of obligor as specified in its charter)

 

 

 

Delaware   27-4326290
(State of incorporation)  

(I.R.S. employer

identification no.)

200 Sidney Street – 4th Floor

Cambridge, MA

  02139
(Address of principal executive offices)   (Zip Code)

 

 

Debt Securities

(Title of the indenture securities)

 

 

 


© Seres Therapeutics. All Rights Reserved.